On this page
Typically prepared by a compounding pharmacy under the direction of a licensed healthcare professional — not an FDA-approved finished product in this form.
Overview
Product & regulatory status
Compounded creams are not FDA-approved finished products; approved testosterone gels are a different product category.
Topical delivery
Testosterone crosses the skin from a vehicle; laboratory release differs among preparations, so the vehicle is part of the medicine. [1]
What the evidence shows
Measured concentration can vary
A blinded 2015 study tested two batches from ten Toronto compounding pharmacies. Only half of first batches and 30% of second batches were within 20% of the prescribed concentration. It was a small regional sample, not an assessment of every pharmacy today. [2]
Similar labels do not prove equivalence
A laboratory comparison of topical preparations found differences in release behavior and impurity profiles. These measurements do not establish which cream improves symptoms, but they undermine assumptions that all topical testosterone products are equivalent. [1]
What remains unknown
A concentration on the container does not by itself establish absorbed exposure. The cited analytical studies cannot predict the quality of a specific present-day product.
Safety
Secondary exposure
Approved testosterone-gel labeling warns about transfer to other people, including children. A compounded cream needs its own product-specific precautions rather than an assumption that skin delivery stays local. [4]
Unexpected exposure
Variation in measured content is a reason to review unexpected results with the prescriber and dispensing pharmacy rather than infer a new hormone requirement. [2]
Cream versus approved gel
An approved gel’s trial results do not establish bioequivalence for a separately compounded cream. [3]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [5]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [6]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is a cream “bioidentical,” and therefore risk-free?
A molecule matching the body’s hormone does not remove exposure-related effects or establish the quality of the finished product.
Which details make records useful?
Record the base, concentration, dispenser and pharmacy when products change.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Analytical evaluation of topical testosterone products2008 laboratory comparison of topical preparations; content, impurities and release behavior, not a patient-outcome trial.
- Grober et al.: compounded testosterone contentJournal of Sexual Medicine, 2015; blinded testing of two batches from ten Toronto compounding pharmacies.
- FDA: compounding questions and answersFDA explanation of compounded-drug approval and quality differences; accessed September 9, 2026.
- Fortesta prescribing informationFDA 2025 testosterone-gel label; secondary exposure and androgen safety warnings, not a compounded-cream equivalence study.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.